Somatization occurs when psychological distress manifests as physical symptoms in the body. For example, someone experiencing intense grief might develop severe fatigue, or a person under chronic stress may experience persistent headaches or digestive issues. Though these symptoms lack an identifiable medical cause, they are very real and can significantly impact daily functioning.
The prefix "soma" comes from the Greek word for body, reflecting how our minds and bodies are deeply interconnected. Understanding somatization is crucial because it affects millions of people worldwide and often leads to extensive medical evaluations, healthcare costs, and personal suffering before the psychological roots are recognized and addressed.
Table of Contents
- What Is Somatization?
- Prevalence and Demographics
- Somatic Symptom Disorder
- Conversion Disorder
- What Causes Somatization?
- Risk Factors and Development
- Treatment Approaches
- Frequently Asked Questions
- How Therapy Can Help
What Is Somatization?
Somatization refers to the tendency to experience and express psychological distress through physical symptoms. According to the DSM-5, somatic symptom disorder (SSD) involves one or more physical symptoms accompanied by excessive thoughts, emotions, and/or behaviors related to the symptom that result in significant distress and/or dysfunction. These symptoms may range from pain and fatigue to neurological symptoms like numbness or difficulty swallowing.
Most people experience occasional somatization during times of stress — throwing up from anxiety before a presentation, developing tension headaches during exam periods, or feeling physically weak after trauma are common examples. These symptoms may or may not be explained by a medical condition. What distinguishes clinical somatization is its persistence, severity, and the significant distress it causes.
It's essential to understand that somatic symptoms are not:
- Fake or imaginary
- Signs of weakness or attention-seeking
- Under conscious control
- Malingering (pretending to be sick for gain)
The pain, discomfort, and dysfunction are genuine, regardless of whether a medical explanation exists. The best-suited approach is stepped care with close cooperation of primary care, a somatic specialist, and mental health care professionals operating on the basis of a biopsychosocial model.
Prevalence and Demographics
Recent research reveals somatization is more common than previously thought:
SSD is believed to affect approximately 5% to 7% of the overall population, with a higher occurrence among females (with a female-to-male ratio of 10:1). The prevalence increases to approximately 17% of the primary care patient population
The pooled prevalence of somatoform disorders was 4.6% (95% CI 3.1–7.0). Prevalence among females (7.7% [5.1–11.5]) was significantly higher than among males (2.8% [1.8–4.3], p<0.0001)
The pooled global prevalence rate was 31.0% for somatoform symptoms and 3.3% for somatoform disorders in children and adolescents- N = 1944 people (mean age 64.8 ± 8 years, 43.8% female) reported at least one major medical disorder. Of those, 6.8% [95% CI 5.6-7.9%] were at risk of SSD
Somatic Symptom Disorder
Somatic Symptom Disorder (SSD) represents the primary diagnosis for persistent somatization. SSD is a recently defined diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). The new criteria eliminated somatization disorder, undifferentiated somatoform disorder, hypochondriasis, and pain disorder from the previous definitions.
Diagnostic Criteria
For an SSD diagnosis, a person must have:
1. One or more somatic symptoms causing distress or disruption
2. Excessive thoughts, feelings, or behaviors related to the symptoms:
- Disproportionate and persistent thoughts about symptom seriousness
- Persistently high anxiety about health or symptoms
- Excessive time and energy devoted to symptoms or health concerns
1. Symptoms persisting for at least 6 months
Key Features
Suffering is not confined to the experience of bodily complaints; it also entails psychological and behavioral aspects like high health anxiety and checking behavior. The spectrum of severity is wide, from mild symptoms with little functional impairment to severely disabling conditions.
Common symptoms include:
- Chronic pain (most frequent)
- Gastrointestinal issues
- Fatigue and weakness
- Cardiovascular symptoms (palpitations, chest pain)
- Neurological symptoms (headaches, dizziness)
- Respiratory difficulties
Distinguishing SSD from Medical Conditions
The two major changes to the DSM-IV criteria included eliminating the requirement that somatic symptoms be organically unexplained and adding the requirement that certain psychobehavioral features have to be present to justify the diagnosis. In previous editions, the diagnosis could not be made unless somatic symptoms were not able to be explained clinically.
This change reflects growing understanding that:
- Many medical conditions involve both physical and psychological factors
- Requiring "medically unexplained" symptoms delayed proper diagnosis and treatment
- The psychological response to symptoms is often more impairing than the symptoms themselves
Conversion Disorder
Conversion Disorder (Functional Neurological Symptom Disorder) involves neurological symptoms without compatible neurological disease. While physical symptoms of medical conditions can vary and new symptoms may appear, most diseases tend to produce specific, primary symptoms rather than a broad spectrum. As Stefan Risberg, a senior family doctor, states: "Most diseases produce distinct symptoms that are dominant, not a myriad of symptoms."
Common Conversion Symptoms:
- Motor symptoms (weakness, paralysis, abnormal movements, tremors)
- Non-epileptic seizures
- Sensory symptoms (blindness, deafness, numbness)
- Speech difficulties (aphonia, dysarthria)
Diagnosis
Diagnosis requires demonstrating incompatibility between symptoms and recognized neurological conditions through clinical examination and testing. For example, someone with non-epileptic seizures may shake and appear unconscious, but EEG patterns won't match those of epilepsy.
What Causes Somatization?
Research identifies multiple contributing factors to somatization:
1. Biological Factors
- Heightened sensitivity: Some individuals have increased awareness of bodily sensations
- Stress response: Research indicates that individuals with high levels of alexithymia are more likely to somaticize emotional distress, expressing their emotional turmoil through physical symptoms rather than recognizing them as emotional experiences
- Genetic predisposition: A study examining monozygotic and dizygotic twins revealed that genetic factors accounted for 7% to 21% of somatic symptoms, while environmental factors accounted for the remaining portion. Another study identified various single nucleotide polymorphisms associated with somatic symptoms
2. Trauma and Stress-
Trauma-related symptoms are closely linked to somatic symptoms among female clinical populations. Findings emphasize the need for trauma-informed screening and treatment to effectively identify Somatic Symptom Disorders and manage somatic symptoms in mental health settings
Our study reveals that cumulative trauma influences somatization, which then mediates psychological distress, ultimately leading to a lower quality of life. Cumulative trauma had the highest negative impact on mental health outcomes
The present study extends extant research demonstrating that greater exposure to interpersonal trauma is significantly and strongly associated with increased somatic symptoms, psychological distress partially accounts for these associations. With replication, these findings inform theoretical frameworks of the psychological underpinnings of somatic symptom development
3. Psychological Factors
- Defense mechanism: Somatization may protect against emotional overwhelm
- Alexithymia: Difficulty identifying and expressing emotions- Negative affectivity and feelings of incompetence significantly predicted somatization, explaining 42% of the variance. Feeling incompetent and negative affectivity did significantly predict somatization in this sample, together accounting for 42% of the somatoform symptom variance
4. Cultural and Social Factors
- Some cultures stigmatize emotional expression more than physical complaints
- Healthcare systems may inadvertently reinforce focus on physical symptoms
- Family patterns of illness behavior and symptom expression
5. Neurobiological Mechanisms
Embedding psychological distress into a physical, somatic reality. Neurological investigations, particularly using functional neuroimaging, reveal that these disorders are not fabricated but are rooted in aberrant neural circuitry. Conditions like functional neurological disorder (FND) are characterized by disrupted connectivity between emotion-processing centers (e.g., the amygdala) and sensorimotor pathways, leading to involuntary physical symptoms
Risk Factors and Development
Several factors increase the risk of developing somatization:
Demographic Risk Factors
- Gender: Women are diagnosed more frequently than men
- Age: It can manifest during childhood, adolescence, or adulthood
- Socioeconomic status: Logistic regression identified higher age (p=.032), lower education (p=.002), number of somatic comorbidities (p<.001), and elevated neuroticism (p<.001) and depression (p<.001) scores as factors associated with risk of SSD
Psychological Risk Factors
- History of anxiety or depression
- Personality traits (neuroticism, negative affectivity)
- Poor coping strategies
- Low self-efficacy- Positive correlations between SD/SSD and dimensionally measured personality functioning were present in four studies (N = 1741). In three studies (N = 2025) correlations between SD/SSD and neuroticism/negative affectivity (d = 0.22-1.041) were present
Environmental Risk Factors
- Childhood adversity
- Family dysfunction
- Medical trauma
- Cultural attitudes toward emotional expression
Treatment Approaches
Evidence-based treatments for somatization have shown significant effectiveness:
Cognitive Behavioral Therapy (CBT)
Meta-analyses indicate that psychotherapy in the cognitive behavioral approach in patients suffering from somatoform disorders significantly reduces the intensity of somatic complaints and the signs of anxiety and depression and improves their physical functioning. The best results were obtained during psychotherapy lasting longer than 12 sessions. These positive effects lasted from three months to one year. Group therapy contributed most to minimizing somatic symptoms, while individual psychotherapy was most effective in reducing signs of depression and anxiety.
The main analysis revealed that CBT could alleviate somatic symptoms: -1.31 (95% CI: -2.23 to -0.39, p = 0.005); anxiety symptoms: -1.89 (95% CI: -2.91 to -0.86; p < 0.001); depressive symptoms: -1.93 (95% CI: -3.56 to -0.31; p = 0.020); improve physical functioning: 4.19 (95% CI: 1.90 to 6.49; p < 0.001). The efficacy of CBT on alleviating somatic symptoms, anxiety and depressive symptoms was sustained on follow-up.
Group Psychotherapy
Both IGPT and SGPT showed significantly lower SSD-12 scores at the 4, 8, and 12-week follow-ups compared to TAU. No significant differences were observed between IGPT and SGPT at any follow-up point. These findings highlight the potential benefits of group psychotherapy in SSD treatment.
When comparing pre- and post-group, we observed reductions in the mean scores for somatic symptom severity, depressive symptomatology, anxiety, perceived stress, and perceived disability related to pain. The change in depressive symptomatology yielded a small effect size (d = 0.30). Current findings provide support for the potential effectiveness of an abbreviated CBT group for individuals with SSD in reducing psychiatric symptomatology.
Mindfulness-Based Interventions
Evidence supports the role of cognitive behavior therapy (CBT), mindfulness-based interventions, acceptance and commitment therapy, and relaxation therapy in the management of individual subtypes of somatoform disorders. There are specific forms of psychotherapy described for specific somatoform autonomic dysfunction, for example, gut-directed psychotherapy for patients with irritable bowel syndrome.
Emotion-Focused Approaches
Affect-focused psychodynamically informed treatments, such as Emotional Awareness and Expression Therapy (EAET) and Intensive Short-Term Dynamic Psychotherapy (ISTDP), have shown significant effectiveness in treating various Functional Somatic Disorders (FSD). For instance, EAET has been compared with Cognitive Behavioral Therapy (CBT) in three randomized controlled trials involving patients with fibromyalgia, musculoskeletal pain, or chronic pain. These studies demonstrated that a significantly higher percentage of patients experienced substantial pain reduction with EAET compared to CBT. Across these trials, an average of 30% of patients experienced a reduction in their pain by 50% or more after the group EAET, but only an average of 5.5% in the CBT group.
Multimodal Treatment
This review gives an overview of the management of somatic symptom disorder. It starts with a description of the clinical problem, discusses classificatory, epidemiological, and etiological issues and then describes the evidence and practical principles of dealing with these patients. It is concluded that the best-suited approach is stepped care with close cooperation of primary care, a somatic specialist, and mental health care professionals operating on the basis of a biopsychosocial model of integrating somatic as well as psychosocial determinants of distress and therapeutic factors.
Treatment Considerations for Special Populations
Somatic symptoms improved significantly in the adult group but not in the elderly group. There was a large, significant decrease in pain intensity and pain disability in elderly patients compared to the adults. This study shows that CBT is feasible as a treatment for SSD in older adults and has encouraging results.
Frequently Asked Questions
What's the difference between somatization and hypochondria?
While both involve physical symptoms and health concerns, somatization focuses on the actual experience of symptoms (real pain, fatigue, etc.), while hypochondria (now called illness anxiety disorder) primarily involves excessive worry about having a serious illness, often without significant physical symptoms. The DSM-5 eliminated hypochondriasis and incorporated most individuals previously diagnosed with hypochondriasis into SSD.
Can children experience somatization?
Yes, somatization can occur at any age. Somatic symptoms affect approximately 25% of children and adolescents, with a significant impact in 10%, and somatization disorders affect 1%-3% of the population. Common symptoms in children include stomachaches, headaches, and fatigue, often related to school stress or family issues.
Is somatization "all in my head"?
No. While psychological factors contribute to somatization, the physical symptoms are real and cause genuine suffering. Modern research shows that somatization disorders have been recognized as a transdiagnostic phenomenon and have been identified in multiple psychiatric disorders. There is evidence of attention and executive function impairments in individuals with undifferentiated somatoform disorders, SSD or body dysmorphic disorders.
How long does treatment typically take?
Treatment duration varies by individual, but CBT is effective for somatoform disorders and MUPS, reducing physical symptoms, psychological distress and disability. The effects of CBT on alleviating somatic symptoms, anxiety and depressive symptoms could sustain on follow-up. Most structured CBT programs run 12-18 sessions, with improvements often beginning within 4-8 weeks.
Can medication help with somatization?
While medication isn't the primary treatment for somatization, it may help manage co-occurring conditions like depression or anxiety. SSD can be resistant to standard treatment modalities like Cognitive Behavioral Therapy (CBT), Selective Serotonin Reuptake Inhibitors (SSRIs), and Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs). The gold standard for the management of SSD is psychotherapy, with Cognitive Behavioral Therapy (CBT) showing significant improvement in patient functionality.
Will my symptoms ever completely go away?
Many people experience significant improvement with treatment. While some may continue to have occasional symptoms during stress, they learn to manage them effectively. The goal is reducing symptom severity, improving function, and enhancing quality of life rather than complete symptom elimination.
How Therapy Can Help
If you're experiencing persistent physical symptoms that interfere with your life, a mental health professional can help. Therapists specializing in somatization and mind-body approaches can:
- Help identify connections between emotions and physical symptoms
- Teach coping strategies for managing symptoms
- Address underlying trauma or stress
- Improve emotional awareness and expression
- Reduce health anxiety and symptom-focused behaviors
- Enhance overall functioning and quality of life
Remember, seeking help for somatization isn't admitting the symptoms are "fake" — it's recognizing the complex relationship between mind and body and taking steps toward healing both.
Find a Therapist: Connect with mental health professionals experienced in treating somatic symptoms through the GoodTherapy directory. Many therapists offer specialized approaches including CBT, mindfulness-based therapies, and trauma-informed care specifically designed for somatization concerns.
References:
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
- Buck, L., Peters, L., Maehder, K., Hartel, F., Hoven, H., Harth, V., Härter, M., Löwe, B., & Toussaint, A. (2025). Risk of somatic symptom disorder in people with major medical disorders: Cross-sectional results from the population-based Hamburg City Health Study. Journal of Psychosomatic Research, 189, 111997. https://doi.org/10.1016/j.jpsychores.2024.111997
- Centers for Disease Control and Prevention. (2024). Mental health data channel. U.S. Department of Health and Human Services. https://www.cdc.gov/mental-health/about-data/index.html
- D'Souza, R. S., & Hooten, W. M. (2023, March 13). Somatic symptom disorder. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532253/
- Del Casale, A., Ferracuti, S., Modesti, M. N., et al. (2024). How does trauma make you sick? The role of attachment in explaining somatic symptoms of survivors of childhood trauma. Healthcare, 12(2), 203. https://doi.org/10.3390/healthcare12020203
- Geremek, A., Lindner, C., Jung, M., et al. (2024). Prevalence of somatic symptoms and somatoform disorders among a German adolescent psychiatric inpatient sample. Children, 11(3), 280. https://doi.org/10.3390/children11030280
- Henningsen, P. (2018). Management of somatic symptom disorder. Dialogues in Clinical Neuroscience, 20(1), 23-31. https://doi.org/10.31887/DCNS.2018.20.1/phenningsen
- Jesuthasan, J., Moran, J. K., Döring-Brandl, E. J., et al. (2025). Relationship between traumatic events, somatization, psychological distress, and quality of life in female refugees in Germany. Frontiers in Psychiatry, 16, 1627665. https://doi.org/10.3389/fpsyt.2025.1627665
- Jongsma, K., Darboh, B. S., Davis, S., & MacKillop, E. (2023). A cognitive behavioural group treatment for somatic symptom disorder: A pilot study. BMC Psychiatry, 23, 896. https://doi.org/10.1186/s12888-023-05141-9
- Kroenke, K., & Sharpe, M. (2024). Somatic symptom disorder: Assessment and treatment approaches. JAMA Psychiatry, 81(2), 150-158. https://doi.org/10.1001/jamapsychiatry.2023.4530
- Lay, C. M., Yuan, G. F., & Wang, E. K. S. (2025). Somatic symptom burden, PTSD, and dissociation: Cross-sectional findings from 995 international female mental health service users. Journal of Psychosomatic Research, 195, 112172. https://doi.org/10.1016/j.jpsychores.2025.112172
- Liu, J., Gill, N. S., Teodorczuk, A., Li, Z. J., & Sun, J. (2019). The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials. Journal of Affective Disorders, 245, 98-112. https://doi.org/10.1016/j.jad.2018.10.114
- Löwe, B., Levenson, J., Depping, M., et al. (2022). Somatic symptom disorder: A scoping review on the empirical evidence of a new diagnosis. Psychological Medicine, 52(4), 632-648. https://doi.org/10.1017/S0033291721004177
- National Alliance on Mental Illness. (2025). Mental health by the numbers. NAMI. https://www.nami.org/about-mental-illness/mental-health-by-the-numbers/
- Perez, L. A., & Szabo, Y. Z. (2025). Somatic symptoms among young adults: An observational study examining the roles of trauma type and psychological distress. BMC Psychology, 13, 301. https://doi.org/10.1186/s40359-025-02504-7
- Substance Abuse and Mental Health Services Administration. (2024). 2024 National Survey on Drug Use and Health (NSDUH) releases. U.S. Department of Health and Human Services. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024
- The Lancet Psychiatry. (2025). The prevalence and estimated burden of somatoform disorders: A systematic review and meta-analysis of their epidemiology. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(25)00272-X
- Vesterling, C., Schütz-Wilke, J., Bäker, N., Bolz, T., Eilts, J., Koglin, U., Rademacher, A., & Goagoses, N. (2023). Epidemiology of somatoform symptoms and disorders in childhood and adolescence: A systematic review and meta-analysis. Health and Social Care in the Community, 2023, 6242678. https://doi.org/10.1155/2023/6242678
- Wang, Y., Li, L., Huang, L., Ma, J., Zheng, L., Fritzsche, K., Leonhart, R., Toussaint, A. C., Schaefert, R., & Zhang, L. (2024). Integrative group psychotherapy for patients with somatic symptom disorder: A randomized controlled trial. Psychiatry Research, 331, 115660. https://doi.org/10.1016/j.psychres.2023.115660
- Xu, L., Shi, J., & Li, C. (2024). Psychological risk factors of somatic symptom disorder: A systematic review and meta-analysis of cross-sectional and longitudinal studies. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.000205
